Canlyniadau Chwilio - Feixiong Cheng

Mireinio'r Canlyniadau
  1. 1
    Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2

    Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2 gan William R. Martin, Feixiong Cheng

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes

    Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes gan Feixiong Cheng, Junfei Zhao, Zhongming Zhao

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy

    Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy gan Feixiong Cheng, Peilin Jia, Quan Wang, Zhongming Zhao

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    ccmGDB: a database for cancer cell metabolism genes

    ccmGDB: a database for cancer cell metabolism genes gan Pora Kim, Feixiong Cheng, Junfei Zhao, Zhongming Zhao

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes

    A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes gan Feixiong Cheng, Junfei Zhao, Michaela Fooksa, Zhongming Zhao

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Investigating cellular network heterogeneity and modularity in cancer: a network entropy and unbalanced motif approach

    Investigating cellular network heterogeneity and modularity in cancer: a network entropy and unbalanced motif approach gan Feixiong Cheng, Chuang Liu, Bairong Shen, Zhongming Zhao

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Precision medicine review: rare driver mutations and their biophysical classification

    Precision medicine review: rare driver mutations and their biophysical classification gan Ruth Nussinov, Hyunbum Jang, Chung‐Jung Tsai, Feixiong Cheng

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers

    Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers gan Ruth Nussinov, Hyunbum Jang, Chung‐Jung Tsai, Feixiong Cheng

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors

    Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors gan Sara Akhavanfard, Roshan Padmanabhan, Lamis Yehia, Feixiong Cheng, Charis Eng

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Systematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based Approach

    Systematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based Approach gan Junfei Zhao, Feixiong Cheng, Yuanyuan Wang, Carlos L. Arteaga, Zhongming Zhao

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health

    Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health gan Feixiong Cheng, Han Liang, Atul J. Butte, Charis Eng, Ruth Nussinov

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated with Autism Compared to Those Associated with Cancer

    Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated with Autism Compared to Those Associated with Cancer gan Iris Nira Smith, Stetson Thacker, Marilyn Seyfi, Feixiong Cheng, Charis Eng

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    A new precision medicine initiative at the dawn of exascale computing

    A new precision medicine initiative at the dawn of exascale computing gan Ruth Nussinov, Hyunbum Jang, Guy Nir, Chung‐Jung Tsai, Feixiong Cheng

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology

    Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology gan Jie Li, Zengrui Wu, Feixiong Cheng, Weihua Li, Guixia Liu, Yun Tang

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Systematic dissection of dysregulated transcription factor–miRNA feed-forward loops across tumor types

    Systematic dissection of dysregulated transcription factor–miRNA feed-forward loops across tumor types gan Wei Jiang, Ramkrishna Mitra, Chen-Ching Lin, Quan Wang, Feixiong Cheng, Zhongming Zhao

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Studying Tumorigenesis through Network Evolution and Somatic Mutational Perturbations in the Cancer Interactome

    Studying Tumorigenesis through Network Evolution and Somatic Mutational Perturbations in the Cancer Interactome gan Feixiong Cheng, Peilin Jia, Quan Wang, Chen-Ching Lin, Wen‐Hsiung Li, Zhongming Zhao

    Cyhoeddwyd 2014
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis

    Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis gan Feixiong Cheng, James L. Murray, Junfei Zhao, Jinsong Sheng, Zhongming Zhao, Donald H. Rubin

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Entropy-based consensus clustering for patient stratification

    Entropy-based consensus clustering for patient stratification gan Hongfu Liu, Rui Zhao, Hong-Sheng Fang, Feixiong Cheng, Yun Fu, Yang‐Yu Liu

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Alzheimer's disease drug development pipeline: 2023

    Alzheimer's disease drug development pipeline: 2023 gan Jeffrey L. Cummings, Yadi Zhou, Garam Lee, Kate Zhong, Jorge Ramón Fonseca Cacho, Feixiong Cheng

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Alzheimer's disease drug development pipeline: 2024

    Alzheimer's disease drug development pipeline: 2024 gan Jeffrey L. Cummings, Yadi Zhou, Garam Lee, Kate Zhong, Jorge Ramón Fonseca Cacho, Feixiong Cheng

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: